Foresite Capital has been proud to partner with Thyme Care since co-leading the Series B in 2023.
Public source
Publisher name
Public post
Congratulations to Robin, Bobby, Brad, and the entire Thyme Care team on the announcement of a $125M+ Series E and the launch of Thyme Companies to expand their impact a…
Company
Foresite Capital
A multi-stage life sciences investment firm with ~ $3.5B in assets under management (as of 06/30/24).
- Industry
- Venture Capital and Private Equity Principals
- Location
- Larkspur, US
- Company size
- 51–200 employees
About Foresite Capital
Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 06/30/24). The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare, including 10x Genomics, Relay Therapeutics, Element Biosciences, Inscripta, as well as companies developing next generation therapeutics. Founded in 2011, Foresite Capital is based in San Francisco.
See moreLatest activity
Latest activity from Foresite Capital
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
Concord Health Partners
Concord Health Partners continued its partnership with Thyme Care to support the company's expansion of its platform with innovative services and solutions advancing cancer care.
Capital & Finance
Frist Cressey Ventures
Frist Cressey Ventures backed Thyme Care nearly six years later, supporting over 135,000 people living with cancer and managing over $7B in oncology spend.
Partnerships
Segal Ventures
Segal Ventures partnered with Jenny Fielding at Everywhere Ventures to support Lauren and her team in their work with Conceive.
Partnerships
FirsthandVC
FirsthandVC backed Takeda put Weave Bio to work across 14 active programs.
Partnerships
Opal Ventures